---
url: https://www.npr.org/sections/shots-health-news/2025/05/21/nx-s1-5403736/first-fda-alzheimers-blood-test-cleared-diagnosis
title: First FDA-cleared Alzheimer's blood test could make diagnoses faster, more
  accurate
publisher: npr
usage: candidate
initial_rank: 2
---
## Article summary
The first blood test for Alzheimer's, cleared by the FDA, is set to enhance the speed and accuracy of diagnoses for individuals aged 55 and older exhibiting cognitive symptoms. This test detects amyloid plaques, which are indicative of Alzheimer's, and could significantly improve diagnostic accuracy, raising correct identification rates from about 60% to over 90%. Unlike traditional methods such as PET scans or spinal taps, which can be expensive or invasive, this blood test offers a more accessible alternative. The test is expected to facilitate earlier diagnoses, allowing for timely treatment with existing amyloid-reducing drugs. A survey indicated that many older Americans would opt for such a blood test to determine their Alzheimer's status. The FDA-cleared test aims to democratize Alzheimer's testing, especially for those in rural or underserved areas, potentially increasing the number of formal diagnoses among the estimated 7.2 million Americans living with the disease. The Alzheimer's Association is developing guidelines to help healthcare providers communicate test results and treatment options to patients. These guidelines are anticipated to be released this summer. Overall, this advancement is poised to revolutionize Alzheimer's care and diagnosis.
